- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 233/26 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
Patent holdings for IPC class C07C 233/26
Total number of patents in this class: 14
10-year publication summary
3
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Risen (Suzhou) Pharma Tech Co., Ltd. | 66 |
2 |
Shanghai Junshi Biosciences Co., Ltd. | 112 |
2 |
Suzhou Abogen Biosciences Co., Ltd. | 74 |
2 |
Merck Patent GmbH | 5815 |
1 |
Katayama Chemical Industries Co., Ltd. | 19 |
1 |
Ono Pharmaceutical Co., Ltd. | 432 |
1 |
Sentient LifeSciences, Inc. | 3 |
1 |
University of Cincinnati | 871 |
1 |
Neoleukin Therapeutics, Inc. | 14 |
1 |
Celloram Inc. | 7 |
1 |
Novius Therapeutics, LLC | 1 |
1 |
Other owners | 0 |